Supriya Lifescience Ltd - Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Download 
|
< Back |
| 10 Aug 2024 | |
| Pursuant to Regulation 33 read with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Board of Directors of the Company at its Meeting held on Saturday, August 10, 2024, inter-alia, has 1. Considered and approved the Unaudited Financial Results for the Quarter ended June 30, 2024 2. Approved the additional Capital Expenditure at Ambernath site for CDMO facility. | |
| View all announcements for Supriya Lifescience Ltd | Source: BSE India |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback